Inducible nitric oxide synthase involvement in the mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhoea in rats

Nitric Oxide - Biology and Chemistry

Volumn 13, Issue 3, 2005, Pages 163-169

  Girard, Philippe ^a   Pansart, Yannick ^a   Gillardin, Jean Marie ^a  

^a Service de Pharmacologie   (France)

Author keywords

Castor oil; Diarrhoea; Inducible nitric oxide synthase; Nitric oxide; Saccharomyces boulardii; Yeast

Indexed keywords

CITRULLINE; DEXAMETHASONE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SACCHAROMYCES BOULARDII;

ANIMALS; BIOLOGICAL THERAPY; CASTOR OIL; CITRULLINE; COLON; DIARRHEA; ISOENZYMES; MALE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; SACCHAROMYCES;

SACCHAROMYCES BOULARDII;

EID: 26644452974     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2005.06.001     Document Type: Article

References (51)

1. L.V. McFarland, and P. Bernasconi Saccharomyces boulardii: a review of an innovative biotherapeutic agent Microb. Ecol. Health Dis. 6 1993 157 171
2. P. Periti, and F. Tonelli Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii J. Chemother. 13 2001 473 493
3. C.M. Surawicz, G.W. Elmer, P. Speelman, L.V. McFarland, J. Chinn, and G. van Belle Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study Gastroenterology 96 1989 981 988
4. L.V. McFarland, C.M. Surawicz, R.N. Greenberg, G.W. Elmer, K.A. Moyer, S.A. Melcher, K.E. Bowen, and J.L. Cox Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo Am. J. Gastroenterol. 90 1995 439 448
5. M. Kotowska, P. Albrecht, and H. Szajewska Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial Aliment. Pharmacol. Ther. 21 2005 583 590
6. O. Erdeve, U. Tiras, and Y. Dallar The probiotic effect of Saccharomyces boulardii in a pediatric age group J. Trop. Pediatr. 50 2004 234 236
7. L.V. McFarland, C.M. Surawicz, R.N. Greenberg, R. Fekety, G.W. Elmer, K.A. Moyer, S.A. Melcher, K.E. Bowen, J.L. Cox, and Z. Noorani A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease JAMA 271 1994 1913 1918
8. C.M. Surawicz, L.V. McFarland, R.N. Greenberg, M. Rubin, R. Fekety, M.E. Mulligan, R.J. Garcia, S. Brandmarker, K. Bowen, D. Borjal, and G.W. Elmer The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii Clin. Infect. Dis. 31 2000 1012 1017
9. K. Plein, and J. Hotz Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea-a pilot study Z. Gastroenterol. 31 1993 129 134
10. G. Philippe-Taine, L. Coroler, R.H. Levy, and J.M. Gillardin Dose-dependent preventive effect of Saccharomyces boulardii on clindamycin-induced alterations in intestinal aerobic flora of the hamster Microb. Ecol. Health Dis. 15 2003 126 130
11. J. Massot, O. Sanchez, R. Couchy, J. Astoin, and A.L. Parodi Bacterio-pharmacological activity of Saccharomyces boulardii in clindamycin-induced colitis in the hamster Arzneimittelforschung 34 1984 794 797
12. R.D. Toothaker, and G.W. Elmer Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii Antimicrob. Agents Chemother. 26 1984 552 556
13. G. Corthier, F. Dubos, and R. Ducluzeau Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii Can. J. Microbiol. 32 1986 894 896
14. P. Girard, Y. Pansart, I. Lorette, and J.M. Gillardin Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats Dig. Dis. Sci. 48 2003 770 774
15. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev. 43 1991 109 142
16. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
17. Q.W. Xie, H.J. Cho, J. Calaycay, R.A. Mumford, K.M. Swiderek, T.D. Lee, A. Ding, T. Troso, and C. Nathan Cloning and characterization of inducible nitric oxide synthase from mouse macrophages Science 256 1992 225 228
18. C.R. Lyons, G.J. Orloff, and J.M. Cunningham Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line J. Biol. Chem. 267 1992 6370 6374
19. B.L. Tepperman, J.F. Brown, and B.J. Whittle Nitric oxide synthase induction and intestinal epithelial cell viability in rats Am. J. Physiol. 265 1993 G214 G218
20. N.K. Boughton-Smith, S.M. Evans, C.J. Hawkey, A.T. Cole, M. Balsitis, B.J. Whittle, and S. Moncada Nitric oxide synthase activity in ulcerative colitis and Crohn's disease Lancet 342 1993 338 340
21. G. Dijkstra, H. Moshage, H.M. van Dullemen, A. Jager-Krikken, A.T. Tiebosch, J.H. Kleibeuker, P.L. Jansen, and H. van Goor Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease J. Pathol. 186 1998 416 421
22. N. Mascolo, A.A. Izzo, F. Barbato, and F. Capasso Inhibitors of nitric oxide synthetase prevent castor-oil-induced diarrhoea in the rat Br. J. Pharmacol. 108 1993 861 864
23. N. Mascolo, A.A. Izzo, G. Autore, F. Barbato, and F. Capasso Nitric oxide and castor oil-induced diarrhea J. Pharmacol. Exp. Ther. 268 1994 291 295
24. E. Beubler, and H. Juan Effect of ricinoleic acid and other laxatives on net water flux and prostaglandin E release by the rat colon J. Pharm. Pharmacol. 31 1979 681 685
25. T.S. Gaginella, and P. Bass Laxatives: an update on mechanism of action Life Sci. 23 1978 1001 1009
26. N. Mascolo, and A.A. Izzo Relationship between nitric oxide and platelet-activating factor in castor-oil induced mucosal injury in the rat duodenum Naunyn Schmiedebergs Arch. Pharmacol. 353 1996 680
27. M.A. Tayeh, and M.A. Marletta Macrophage oxidation of l-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor J. Biol. Chem. 264 1989 19654 19658
28. J.M. Hevel, K.A. White, and M.A. Marletta Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein J. Biol. Chem. 266 1991 22789 22791
29. J.M. Hevel, and M.A. Marletta Nitric-oxide synthase assays Methods Enzymol. 233 1994 250 258
30. S.S. Hedge, T.M. Moy, M.R. Perry, M. Loeb, and R.M. Eglen Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan- induced diarrhea in mice J. Pharmacol. Exp. Ther. 271 1994 741 747
31. N. Mascolo, T.S. Gaginella, A.A. Izzo, G. Di Carlo, and F. Capasso Nitric oxide involvement in sodium choleate-induced fluid secretion and diarrhoea in rats Eur. J. Pharmacol. 264 1994 21 26
32. T.R. Boyde, and M. Rahmatullah Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime Anal. Biochem. 107 1980 424 431
33. A.A. Izzo, N. Mascolo, and F. Capasso Nitric oxide as a modulator of intestinal water and electrolyte transport Dig. Dis. Sci. 43 1998 1605 1620
34. E.P. Garvey, J.A. Oplinger, E.S. Furfine, R.J. Kiff, F. Laszlo, B.J. Whittle, and R.G. Knowles 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo J. Biol. Chem. 272 1997 4959 4963
35. A. Husson, C. Brasse-Lagnel, A. Fairand, S. Renouf, and A. Lavoinne Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle Eur. J. Biochem. 270 2003 1887 1899
36. T.S. Gaginella, N. Mascolo, A.A. Izzo, G. Autore, and F. Capasso Nitric oxide as a mediator of bisacodyl and phenolphthalein laxative action: induction of nitric oxide synthase J. Pharmacol. Exp. Ther. 270 1994 1239 1245
37. S.J. Middleton, M. Shorthouse, and J.O. Hunter Increased nitric oxide synthesis in ulcerative colitis Lancet 341 1993 465 466
38. D. Rachmilewitz, J.S. Stamler, D. Bachwich, F. Karmeli, Z. Ackerman, and D.K. Podolsky Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease Gut 36 1995 718 723
39. H. Kimura, R. Hokari, S. Miura, T. Shigematsu, M. Hirokawa, Y. Akiba, I. Kurose, H. Higuchi, H. Fujimori, Y. Tsuzuki, H. Serizawa, and H. Ishii Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis Gut 42 1998 180 187
40. D. Rachmilewitz, F. Karmeli, and E. Okon Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase Gastroenterology 109 1995 98 106
41. H.G. Seo, I. Takata, M. Nakamura, H. Tatsumi, K. Suzuki, J. Fujii, and N. Taniguchi Induction of nitric oxide synthase and concomitant suppression of superoxide dismutases in experimental colitis in rats Arch. Biochem. Biophys. 324 1995 41 47
42. A. Southey, S. Tanaka, T. Murakami, H. Miyoshi, T. Ishizuka, M. Sugiura, K. Kawashima, and T. Sugita Pathophysiological role of nitric oxide in rat experimental colitis Int. J. Immunopharmacol. 19 1997 669 676
43. A.M. Armstrong, G.R. Campbell, C. Gannon, S.J. Kirk, and K.R. Gardiner Oral administration of inducible nitric oxide synthase inhibitors reduces nitric oxide synthesis but has no effect on the severity of experimental colitis Scand. J. Gastroenterol. 35 2000 832 838
44. L.A. Menchen, A.L. Colon, M.A. Moro, J.C. Leza, I. Lizasoain, P. Menchen, E. Alvarez, and P. Lorenzo N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats Life Sci. 69 2001 479 491
45. E. Kankuri, K. Vaali, R.G. Knowles, M. Lahde, R. Korpela, H. Vapaatalo, and E. Moilanen Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine J. Pharmacol. Exp. Ther. 298 2001 1128 1132
46. R. Korhonen, R. Korpela, and E. Moilanen Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid Inflammation 26 2002 207 214
47. R. Korhonen, R. Korpela, M. Saxelin, M. Maki, H. Kankaanranta, and E. Moilanen Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells Inflammation 25 2001 223 232
48. D.M. McCafferty, J.S. Mudgett, M.G. Swain, and P. Kubes Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation Gastroenterology 112 1997 1022 1027
49. E. Isolauri, M. Juntunen, T. Rautanen, P. Sillanaukee, and T. Koivula A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children Pediatrics 88 1991 90 97
50. O. Shibolet, F. Karmeli, R. Eliakim, E. Swennen, P. Brigidi, P. Gionchetti, M. Campieri, S. Morgenstern, and D. Rachmilewitz Variable response to probiotics in two models of experimental colitis in rats Inflamm. Bowel Dis. 8 2002 399 406
51. S. Ulisse, P. Gionchetti, S. D'Alo, F.P. Russo, I. Pesce, G. Ricci, F. Rizzello, U. Helwig, M.G. Cifone, M. Campieri, and C. De Simone Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment Am. J. Gastroenterol. 96 2001 2691 2699